Clinical trials: Pyridoxine Deficiency
- Condition Pyridoxine Deficiency
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
The proposed clinical study is intended to evaluate oral P5P for the treatment of patients confirmed to have Pyridox(am)ine 5'-Phosphate Oxidase (PNPO) deficiency via genetic analysis.
- Trial name
- MEND-PNPO (NCT04706013)
- Testing
- Pyridoxal Phosphate
- Where
- 7 sites in United States, Australia
- Volunteers
- 15 people
- Sponsor
- Medicure